Naqash, Abdul Rafeh

Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade

Stroud, C. R., Hegde, A., Cherry, C., Naqash, A. R., Sharma, N., Addepalli, S., Cherukuri, S., Parent, T., Hardin, J., & Walker, P. (2019) · Journal of Oncology Pharmacy Practice

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 331

Considerations for treatment duration in responders to immune checkpoint inhibitors

Marron, T. U., Ryan, A. E., Reddy, S. M., Kaczanowska, S., Younis, R. H., Thakkar, D., Zhang, J., Bartkowiak, T., Howard, R., Anderson, K. G., et al. (2021) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 137

Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute—Cancer Therapy Evaluation Program

Naqash, A. R., Moey, M. Y. Y., Cherie Tan, X.-W., Laharwal, M., Hill, V., Moka, N., Finnigan, S., Murray, J., Johnson, D. B., Moslehi, J. J., et al. (2022) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersChemotherapy-induced cardiotoxicity and mitigation

Cited by 87

A Phase 1/2, open label dose-escalation and expansion trial of NKT2152, an orally administered HIF2α inhibitor, to investigate safety, PK, PD and clinical activity in patients with advanced ccRCC

Jonasch, E., Hauke, R., Falchook, G., Logan, T., Gordon, M., Hall, E., Schuch, B., Bilen, M. A., Naqash, A., Zakaharia, Y., et al. (2023) · The Oncologist

Renal cell carcinoma treatmentCancer, Hypoxia, and Metabolism

Cited by 1

First-in-human, phase 1, open-label, dose-escalation, dose-expansion study of ADCT-901 as monotherapy in patients with select advanced solid tumors.

Harvey, R. D., Falchook, G. S., Naqash, A. R., Kim, J. W., Dowlati, A., Le Bruchec, Y., Coudert, I., Ervin-Haynes, A. L., & Sommerhalder, D. (2022) · Journal of Clinical Oncology

Monoclonal and Polyclonal Antibodies ResearchSynthesis and pharmacology of benzodiazepine derivatives

Cited by 1